Tapentadol Hydrochloride
- Product NDC
- 70954-801
- Requested package NDC
- 70954-801-10
- 11-digit product format
- 709540801
- Labeler code
- 70954
- Product ID
- 70954-801_38c1235a-d675-4b2d-b1a5-100427af2364
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tapentadol Hydrochloride
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- ANI Pharmaceuticals, Inc.
- Application
- ANDA219119
- Marketing category
- ANDA
- Marketing start
- 2026-07-13
- Substance
- TAPENTADOL HYDROCHLORIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Opioid Agonist [EPC], Opioid Agonists [MoA]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219119-001 | TAPENTADOL HYDROCHLORIDE | TAPENTADOL HYDROCHLORIDE | EQ 20MG BASE/ML | SOLUTION / ORAL | 2026-01-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A219119-001 | TAPENTADOL HYDROCHLORIDE | EQ 20MG BASE/ML | SOLUTION / ORAL | 2026-01-26 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A219119-001 | TAPENTADOL HYDROCHLORIDE | EQ 20MG BASE/ML | SOLUTION / ORAL | 2026-01-26 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A219119-001 | TAPENTADOL HYDROCHLORIDE | EQ 20MG BASE/ML | SOLUTION / ORAL | 2026-01-26 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A219119-001 | TAPENTADOL HYDROCHLORIDE | EQ 20MG BASE/ML | SOLUTION / ORAL | 2026-01-26 | 011fe1cb6892… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219119-001 | TAPENTADOL HYDROCHLORIDE | EQ 20MG BASE/ML | SOLUTION / ORAL | 2026-01-26 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tapentadol Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TAPENTADOL HYDROCHLORIDE | 20 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 71204KII53 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1356315 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e0ecb809-6a55-4afe-b981-b8f174e5c344 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tapentadol Hydrochloride | TAPENTADOL HYDROCHLORIDE | ANI Pharmaceuticals, Inc. | e0ecb809-6a55-4afe-b981-b8f174e5c344 | 2026-07-27 | Boxed warning, Warnings, Adverse reactions | 219119 ANDA219119 70954-801-10 70954-801 70954080110 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 70954-801-10 | 70954080110 | 1 BOTTLE in 1 CARTON (70954-801-10) / 100 mL in 1 BOTTLE | 1 bottle | 2026-07-13 | No | No | Current |